These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2452802)

  • 21. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum.
    Huff RM; Molinoff PB
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7561-5. PubMed ID: 6961433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic localization of dopamine DA-2 receptor sites in rat mesenteric vascular tree.
    Ricci A; Amenta F
    J Pharmacol Exp Ther; 1990 Aug; 254(2):750-5. PubMed ID: 2143538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Specific binding of 3H-domperidone--a selective ligand of D2-dopamine receptors--by the human caudate nucleus].
    Zlobina GP; Chekalina ND
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1043-5. PubMed ID: 2960110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
    Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
    Monsma FJ; Sibley DR
    Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line.
    Neve KA; Henningsen RA; Bunzow JR; Civelli O
    Mol Pharmacol; 1989 Sep; 36(3):446-51. PubMed ID: 2571073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
    Agui T; Amlaiky N; Caron MG; Kebabian JW
    Mol Pharmacol; 1988 Feb; 33(2):163-9. PubMed ID: 2963208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.
    Boundy VA; Lu L; Molinoff PB
    J Pharmacol Exp Ther; 1996 Feb; 276(2):784-94. PubMed ID: 8632351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
    Turner JT; Ray-Prenger C; Bylund DB
    Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive method for the quantitative determination of dopamine receptor subtypes.
    McGonigle P; Huff RM; Molinoff PB
    Ann N Y Acad Sci; 1984; 430():77-90. PubMed ID: 6331265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.
    De Keyser J; Dierckx R; Vanderheyden P; Ebinger G; Vauquelin G
    Brain Res; 1988 Mar; 443(1-2):77-84. PubMed ID: 2896059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of binding sites for [3H]spiroperidol.
    Luedtke RR; Molinoff PB
    Biochem Pharmacol; 1987 Oct; 36(19):3255-64. PubMed ID: 2959288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.